SCHEMBL12426823

SCHEMBL12426823

C#Cc1cccc(Nc2ncnc3cc(CC)c(OCCCCCCC(=O)O)cc23)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.69
ERBB2 P04626 8/20 0.69
HDAC3 O15379 8/20 0.69
HDAC4 P56524 8/20 0.69
HDAC1 Q13547 8/20 0.69
HDAC7 Q8WUI4 8/20 0.69
HDAC2 Q92769 8/20 0.69
HDAC10 Q969S8 8/20 0.69
HDAC11 Q96DB2 8/20 0.69
HDAC8 Q9BY41 8/20 0.69
HDAC6 Q9UBN7 8/20 0.69
HDAC9 Q9UKV0 8/20 0.69
HDAC5 Q9UQL6 8/20 0.69
GAK O14976 3/20 0.69
RIPK2 O43353 2/20 0.69
BUB1 O43683 2/20 0.69
STK10 O94804 2/20 0.69
ABL1 P00519 2/20 0.69
LCK P06239 2/20 0.69
LYN P07948 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12426798 0.90 EGFR (0.84) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL12426810 0.90 EGFR (0.68) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL12426799 0.89 EGFR (0.84) EGFRERBB2HDAC3HDAC4HDAC1
Erlotinib SCHEMBL27974794 0.87 EGFR (0.82) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL642033 0.84 EGFR (0.83) EGFRERBB2HDAC3HDAC4HDAC1
Erlotinib SCHEMBL2037601 0.83 EGFR (0.85) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL13882737 0.83 EGFR (0.84) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL12876988 0.83 FBP1 (0.70) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL12518963 0.82 EGFR (0.66) EGFRERBB2HDAC3HDAC4HDAC1
SCHEMBL641765 0.82 EGFR (0.84) EGFRERBB2HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977347-B2 inhibitors of epidermal growth factor receptor tyrosine kinase; anticancer; 6-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)hexanoic acid CURIS, INC. (US) 2011-07-12 US disclosed
US-7977347-B2 inhibitors of epidermal growth factor receptor tyrosine kinase; anticancer; 6-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)hexanoic acid CURIS, INC. (US) 2011-07-12 US disclosed